RGNX

Regenxbio Inc

May 15 • 04:00PM ET

5.72

-0.53 -8.41 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: NGNE FDMT QURE STOK EDIT

| Held by: VTI XBI IWM VXF IWN IBB VTWO FESM KOMP SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-5.59	Insider Own	10.76%	Shs Outstand	51.62M	Perf Week	-45.78%
Market Cap	295.71M	Forward P/E	-	EPS next Y	-2.92	Insider Trans	-0.37%	Shs Float	47.29M	Perf Month	-37.76%
Enterprise Value	393.62M	PEG	-	EPS next Q	0.25	Inst Own	81.43%	Short Float	14.15%	Perf Quarter	-28.41%
Income	-290.01M	P/S	3.37	EPS this Y	24.27%	Inst Trans	-0.49%	Short Ratio	6.47	Perf Half Y	-50.69%
Sales	87.82M	P/B	14.00	EPS next Y	-2.52%	ROA	-69.65%	Short Interest	6.69M	Perf YTD	-60.28%
Book/sh	0.41	P/C	1.96	EPS next 5Y	28.01%	ROE	-196.43%	52W High	16.19 -64.67%	Perf Year	-33.80%
Cash/sh	2.91	P/FCF	-	EPS past 3/5Y	16.67% -4.73%	ROIC	-117.23%	52W Low	6.01 -4.90%	Perf 3Y	-73.65%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	14.78% 1.97%	Gross Margin	50.52%	Volatility	14.67% 8.19%	Perf 5Y	-84.17%
Dividend TTM	-	EV/Sales	4.48	EPS Y/Y TTM	-78.31%	Oper. Margin	-292.28%	ATR (14)	0.87	Perf 10Y	-49.56%
Dividend Ex-Date	-	Quick Ratio	2.62	Sales Y/Y TTM	-43.96%	Profit Margin	-330.23%	RSI (14)	26.72	Recom	1.42
Dividend Gr. 3/5Y	- -	Current Ratio	2.62	EPS Q/Q	-1551.90%	SMA20	-37.00%	Beta	1.07	Target Price	25.92
Payout	-	Debt/Eq	11.78	Sales Q/Q	-92.82%	SMA50	-35.60%	Rel Volume	4.40	Prev Close	6.24
Employees	371	LT Debt/Eq	10.74	Earnings	May 14 BMO	SMA200	-45.82%	Avg Volume	1.04M	Price	5.72
IPO	Sep 17, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-28.65% -75.26%	Trades		Volume	4,342,926	Change	-8.41%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)